Search Results - "Frantzi, Maria"

Validation of a Urine-Based Proteomics Test to Predict Clinically Significant Prostate Cancer: Complementing mpMRI Pathway.

Authors: Frantzi, Maria Morillo, Ana C. Lendinez, Guillermo et al.

Source: Pathobiology. 2025, Vol. 92 Issue 2, p99-108. 10p.

Peptides as "better biomarkers"? Value, challenges, and potential solutions to facilitate implementation.

Authors: Latosinska, Agnieszka Frantzi, Maria Siwy, Justyna

Source: Mass Spectrometry Reviews. Nov2024, Vol. 43 Issue 6, p1195-1236. 42p.

A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data.

Authors: O'Connell, Shea P. Frantzi, Maria Latosinska, Agnieszka et al.

Source: Cancers. Apr2022, Vol. 14 Issue 8, p1995. 17p.

Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.

Authors: Frantzi, Maria Culig, Zoran Heidegger, Isabel et al.

Source: Cancers. Feb2023, Vol. 15 Issue 4, p1166. 23p.

Gene Expression Monotonicity across Bladder Cancer Stages Informs on the Molecular Pathogenesis and Identifies a Prognostic Eight-Gene Signature.

Authors: Stroggilos, Rafael Frantzi, Maria Zoidakis, Jerome et al.

Source: Cancers. May2022, Vol. 14 Issue 10, p2542-N.PAG. 22p.

Novel Strategy for Acquiring Metabolically‐Tagged Nascent Extracellular Vesicles: Implications for Identifying Surface Protein Markers of Extracellular Vesicles From Neuroblastoma Cells Cultured With Native Serum.

Authors: Markus, Hugo P. de Jong, Edwin Makridakis, Manousos et al.

Source: Journal of Extracellular Vesicles. Oct2025, Vol. 14 Issue 10, p1-21. 21p.

Open Access in Greek academic institutions: a profile of researchers' perceptions.

Authors: Frantzi, Maria Salamoura, Athanasia Tsakonas, Giannis

Source: BIT Online. 2022, Vol. 25 Issue 5, p423-429. 7p.

Author Correction: Urinary CE-MS peptide marker pattern for detection of solid tumors.

Authors: Belczacka, Iwona Latosinska, Agnieszka Siwy, Justyna et al.

Source: Scientific Reports. 9/3/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology.

Authors: Fatima, Yasra Jobre, Kirubel Nigusu Gomez-Gomez, Enrique et al.

Source: International Journal of Molecular Sciences. Aug2025, Vol. 26 Issue 15, p7475. 39p.

Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness.

Authors: Lygirou, Vasiliki Fasoulakis, Konstantinos Stroggilos, Rafael et al.

Source: Cancers. Aug2022, Vol. 14 Issue 15, p3765-3765. 15p.

Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.

Authors: Voigtländer, Torsten Metzger, Jochen Husi, Holger et al.

Source: Journal of Biomedical Science. 1/3/2020, Vol. 27 Issue 1, p1-14. 14p. 1 Diagram, 2 Charts, 2 Graphs.

Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer.

Authors: Frantzi, Maria Hupe, Marie C. Merseburger, Axel S. et al.

Source: Diagnostics (2075-4418). Sep2020, Vol. 10 Issue 9, p658. 1p.

Proteomics biomarkers for solid tumors: Current status and future prospects.

Authors: Belczacka, Iwona Latosinska, Agnieszka Metzger, Jochen et al.

Source: Mass Spectrometry Reviews. Jan2019, Vol. 38 Issue 1, p49-78. 30p.

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients' Omics Signatures.

Authors: Mokou, Marika Lygirou, Vasiliki Angelioudaki, Ioanna et al.

Source: Cancers. Dec2020, Vol. 12 Issue 12, p3519. 1p.

Urinary CE-MS peptide marker pattern for detection of solid tumors.

Authors: Belczacka, Iwona Latosinska, Agnieszka Siwy, Justyna et al.

Source: Scientific Reports. 3/27/2018, Vol. 8 Issue 1, pN.PAG-N.PAG. 1p.

Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma.

Authors: Bannaga, Ayman Metzger, Jochen Voigtländer, Torsten et al.

Source: Cancers. Aug2021, Vol. 13 Issue 15, p3786-3786. 1p.

Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of -omics findings.

Authors: Latosinska, Agnieszka Makridakis, Manousos Frantzi, Maria et al.

Source: Scientific Reports. 5/13/2016, p25619. 1p.

Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation.

Authors: Latosinska, Agnieszka Davalieva, Katarina Makridakis, Manousos et al.

Source: Diagnostics (2075-4418). Sep2020, Vol. 10 Issue 9, p655. 1p.

Front Cover: Clinical Proteomics on the Path Toward Implementation: First Promises Delivered.

Authors: Frantzi, Maria Mischak, Harald Latosinska, Agnieszka

Source: Proteomics. Clinical applications Mar2019; Vol. 13 (2).

Journal Info: Publisher: Wiley-Blackwell ISSN: 1862-8346